Sowdhamini S. Wallace
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sowdhamini S. Wallace has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
Pearl W. Chang
Division of Pediatric Hospital Medicine, Department of Pediatrics, University of Washington, School of Medicine and Seattle Children's Hospital, 4800 Sand Point Way NE, Seattle, WA, 98105, USA
3 shared publicationsVijaya Vemulakonda
Division of Pediatric Urology, Department of Surgery, University of Colorado School of Medicine and Children's Hospital Colorado, 13123 East 16th St, Aurora, CO, 80045, USA
3 shared publicationsAmrita Singh
Division of Pediatric Hospital Medicine (JD Ortiz, T Hadvani, S Zafar, R Nicome, K Ban, C Arthur, A Singh, HC Neubauer, and SS Wallace), Department of Pediatrics, Texas Children's Hospital and Baylor College of Medicine, Houston, Tex
2 shared publications- Catherine S. Forster
Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
2 shared publications - Jacqueline G. Holden
Division of Pediatric Hospital Medicine, Department of Pediatrics, University of Pittsburgh 4401 Penn Ave., Pittsburgh, PA 15224, USA
2 shared publications - John Michael Morrison
Division of Pediatric Hospital Medicine, Department of Pediatrics, John Hopkins All Children's Hospital, 501 6th Ave S, St. Petersburg, FL, USA
2 shared publications
Latest Publications
- 12 May 2026
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (5) , 106006
Response to Letter to the Editor re: “Diagnostic evaluation and treatment of UTIs in children with neurogenic bladder”
- 12 May 2026
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (5) , 106006
Response to Letter to the Editor re: “Diagnostic evaluation and treatment of UTIs in children with neurogenic bladder”
- 4 March 2026
- Published by Elsevier in Academic Pediatrics
- Vol. 26 (4) , 103274
Effectiveness of a Multimodal Educational Intervention to Improve Shared Decision-Making Skills Among Pediatric Hospitalists
- 4 March 2026
- Published by Elsevier in Academic Pediatrics
- Vol. 26 (4) , 103274
Effectiveness of a Multimodal Educational Intervention to Improve Shared Decision-Making Skills Among Pediatric Hospitalists
- Open Access
- 17 September 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (1) , 105602
Diagnostic evaluation and treatment of UTIs in children with neurogenic bladder
- 17 September 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (1) , 105602
Open AccessDiagnostic evaluation and treatment of UTIs in children with neurogenic bladder
- 25 March 2025
- Published by American Academy of Pediatrics (AAP) in Hospital Pediatrics
- Vol. 15 (4) , 309-317
Variability in Treatment of UTIs in Children With Genitourinary Anomalies in Children’s Hospitals
OBJECTIVE: In children with urinary tract anomalies, febrile urinary tract infections (UTIs) are associated with increased risks of sepsis, hospitalization, and kidney injury. However, the best treatment strategies are unknown. We aimed to describe antibiotic treatment practices and outcomes for UTIs in children with urinary tract anomalies and evaluate whether variability in UTI treatment exists between hospitals. METHODS: We conducted a multicenter retrospective cohort study of children seen in emergency departments (EDs) in 6 free-standing US children’s hospitals from January 1, 2017, through December 31, 2018. We included children aged 0–17 years with an anatomic or functional urinary tract anomaly and a physician diagnosis of febrile or hypothermic UTI. Outcomes included intravenous (IV) antibiotic administration practices, hospitalization rates, length of stay, and return ED visits. Multivariable logistic and linear regression were performed, adjusting for differences in patient and illness characteristics. RESULTS: Among the 510 children included, anomaly types, presence of home catheterization regimens, and baseline glomerular filtration rates varied between sites. In the adjusted analyses, sites differed in several treatment practices: IV antibiotic administration before ED discharge (P = .007), IV antibiotic spectrum (P = .003), IV antibiotic duration (P < .001), and hospital length of stay (P < .001). No statistically significant differences existed with bacteremia (P = .24) or intensive care stays (P = .08). Returns to the ED within 30 days did not significantly differ by site (P = .68). CONCLUSIONS: Children’s hospitals vary in their treatment of UTIs in children with urinary tract anomalies, yet ED revisits are similar across sites, highlighting the opportunity to promote high-value care in treatment of UTIs in this population.
- 25 March 2025
- Published by American Academy of Pediatrics (AAP) in Hospital Pediatrics
- Vol. 15 (4) , 309-317
Variability in Treatment of UTIs in Children With Genitourinary Anomalies in Children’s Hospitals
OBJECTIVE: In children with urinary tract anomalies, febrile urinary tract infections (UTIs) are associated with increased risks of sepsis, hospitalization, and kidney injury. However, the best treatment strategies are unknown. We aimed to describe antibiotic treatment practices and outcomes for UTIs in children with urinary tract anomalies and evaluate whether variability in UTI treatment exists between hospitals. METHODS: We conducted a multicenter retrospective cohort study of children seen in emergency departments (EDs) in 6 free-standing US children’s hospitals from January 1, 2017, through December 31, 2018. We included children aged 0–17 years with an anatomic or functional urinary tract anomaly and a physician diagnosis of febrile or hypothermic UTI. Outcomes included intravenous (IV) antibiotic administration practices, hospitalization rates, length of stay, and return ED visits. Multivariable logistic and linear regression were performed, adjusting for differences in patient and illness characteristics. RESULTS: Among the 510 children included, anomaly types, presence of home catheterization regimens, and baseline glomerular filtration rates varied between sites. In the adjusted analyses, sites differed in several treatment practices: IV antibiotic administration before ED discharge (P = .007), IV antibiotic spectrum (P = .003), IV antibiotic duration (P < .001), and hospital length of stay (P < .001). No statistically significant differences existed with bacteremia (P = .24) or intensive care stays (P = .08). Returns to the ED within 30 days did not significantly differ by site (P = .68). CONCLUSIONS: Children’s hospitals vary in their treatment of UTIs in children with urinary tract anomalies, yet ED revisits are similar across sites, highlighting the opportunity to promote high-value care in treatment of UTIs in this population.
- 25 July 2023
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 63 (5) , 689-696
Risk Factors for Treatment Failure in Neonates With Skin and Soft Tissue Infection: A Retrospective Cohort Study
We aimed to describe the frequency of treatment failure and associated risk factors for treatment failure amongst neonates with skin and soft tissue infections (SSTIs). We conducted a retrospective cohort study of neonates 0 to 28 days old with uncomplicated SSTIs presenting to the emergency department of a quaternary care children’s hospital from 2009 to 2017. Data were collected via chart review. Skin and soft tissue infections included the following: cellulitis, abscess, mastitis, perirectal SSTI, carbuncle, and furuncle. Of the 202 neonates in the study, most were term, afebrile with mastitis, or perirectal SSTI. Treatment failure occurred in 8% (17/202) of neonates receiving oral antibiotics; 10 of these neonates had perirectal SSTIs and 2 had clindamycin and methicillin-resistant Staphylococcus aureus. Neonates with treatment failure had increased odds of having perirectal SSTIs (odds ratio [OR] = 4.08, 95% confidence interval [CI] = 1.46-11.31). Further studies are needed to identify strategies to prevent treatment failure in neonates with perirectal SSTIs.
- 25 July 2023
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 63 (5) , 689-696
Risk Factors for Treatment Failure in Neonates With Skin and Soft Tissue Infection: A Retrospective Cohort Study
We aimed to describe the frequency of treatment failure and associated risk factors for treatment failure amongst neonates with skin and soft tissue infections (SSTIs). We conducted a retrospective cohort study of neonates 0 to 28 days old with uncomplicated SSTIs presenting to the emergency department of a quaternary care children’s hospital from 2009 to 2017. Data were collected via chart review. Skin and soft tissue infections included the following: cellulitis, abscess, mastitis, perirectal SSTI, carbuncle, and furuncle. Of the 202 neonates in the study, most were term, afebrile with mastitis, or perirectal SSTI. Treatment failure occurred in 8% (17/202) of neonates receiving oral antibiotics; 10 of these neonates had perirectal SSTIs and 2 had clindamycin and methicillin-resistant Staphylococcus aureus. Neonates with treatment failure had increased odds of having perirectal SSTIs (odds ratio [OR] = 4.08, 95% confidence interval [CI] = 1.46-11.31). Further studies are needed to identify strategies to prevent treatment failure in neonates with perirectal SSTIs.
- 1 May 2020
- Published by American Academy of Pediatrics (AAP) in Hospital Pediatrics
- Vol. 10 (5) , 392-400
Clinical Predictors for Abnormal Renal Bladder Ultrasound in Hospitalized Young Children With a First Febrile Urinary Tract Infection
BACKGROUND: Physicians often obtain a routine renal bladder ultrasound (RBUS) for young children with a first febrile urinary tract infection (UTI). However, few children are diagnosed with serious anatomic anomalies, and opportunity may exist to take a focused approach to ultrasonography. We aimed to identify characteristics of the child, prenatal ultrasound (PNUS), and illness that could be used to predict an abnormal RBUS and measure the impact of RBUS on management. METHODS: We conducted a single-center prospective cohort study of hospitalized children 0 to 24 months of age with a first febrile UTI from October 1, 2016, to December 23, 2018. Independent variables included characteristics of the child, PNUS, and illness. The primary outcome, abnormal RBUS, was defined through consensus of a multidisciplinary team on the severity of ultrasound findings important to identify during a first UTI. RESULTS: A total of 211 children were included; the median age was 1.0 month (interquartile range 0–2), and 55% were uncircumcised boys. All mothers had a PNUS with 10% being abnormal. Escherichia coli was the pathogen in 85% of UTIs, 20% (n = 39 of 197) had bacteremia, and 7% required intensive care. Abnormal RBUS was found in 36% (n = 76 of 211) of children; of these, 47% (n = 36 of 76) had moderately severe findings and 53% (n = 40 of 76) had severe findings. No significant difference in clinical characteristics was seen among children with and without an abnormal RBUS. One child had Foley catheter placement, and 33% received voiding cystourethrograms, 15% antibiotic prophylaxis, and 16% subspecialty referrals. CONCLUSIONS: No clinical predictors were identified to support a focused approach to RBUS examinations. Future studies should investigate the optimal timing for RBUS.
- 1 May 2020
- Published by American Academy of Pediatrics (AAP) in Hospital Pediatrics
- Vol. 10 (5) , 392-400
Clinical Predictors for Abnormal Renal Bladder Ultrasound in Hospitalized Young Children With a First Febrile Urinary Tract Infection
BACKGROUND: Physicians often obtain a routine renal bladder ultrasound (RBUS) for young children with a first febrile urinary tract infection (UTI). However, few children are diagnosed with serious anatomic anomalies, and opportunity may exist to take a focused approach to ultrasonography. We aimed to identify characteristics of the child, prenatal ultrasound (PNUS), and illness that could be used to predict an abnormal RBUS and measure the impact of RBUS on management. METHODS: We conducted a single-center prospective cohort study of hospitalized children 0 to 24 months of age with a first febrile UTI from October 1, 2016, to December 23, 2018. Independent variables included characteristics of the child, PNUS, and illness. The primary outcome, abnormal RBUS, was defined through consensus of a multidisciplinary team on the severity of ultrasound findings important to identify during a first UTI. RESULTS: A total of 211 children were included; the median age was 1.0 month (interquartile range 0–2), and 55% were uncircumcised boys. All mothers had a PNUS with 10% being abnormal. Escherichia coli was the pathogen in 85% of UTIs, 20% (n = 39 of 197) had bacteremia, and 7% required intensive care. Abnormal RBUS was found in 36% (n = 76 of 211) of children; of these, 47% (n = 36 of 76) had moderately severe findings and 53% (n = 40 of 76) had severe findings. No significant difference in clinical characteristics was seen among children with and without an abnormal RBUS. One child had Foley catheter placement, and 33% received voiding cystourethrograms, 15% antibiotic prophylaxis, and 16% subspecialty referrals. CONCLUSIONS: No clinical predictors were identified to support a focused approach to RBUS examinations. Future studies should investigate the optimal timing for RBUS.
- 21 August 2018
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 37 (6) , e301-e306
Invasive Bacterial Infections in Infants Younger Than 60 Days With Skin and Soft Tissue Infections
Objective: The objective of this study was to describe the frequency of invasive bacterial infections (IBIs) in young infants with skin and soft tissue infections (SSTIs) and the impact of IBI evaluation on disposition, length of stay (LOS), and cost. Methods: This retrospective (2009–2014) cohort study used data from 35 children's hospitals in the Pediatric Health Information System. We included infants younger than 60 days who presented to an emergency department (ED) with SSTI. Invasive bacterial infection was defined as bacteremia/sepsis, bone/joint infection, or bacterial meningitis. Readmission and return ED visits within 30 days were evaluated to identify missed IBIs for infants. Results: A total of 2734 infants were included (median age, 33 days; interquartile range [IQR], 21–44); 62% were hospitalized. Invasive bacterial infection was identified in 2%: bacteremia (1.8%), osteomyelitis (0.1%), and bacterial meningitis (0.1%). Hospitalization occurred in 78% of infants with blood cultures, 95% with cerebrospinal fluid cultures, and 23% without cultures. Median hospitalization LOS was 2 days (IQR, 1–3). Median cost was US $4943 for infants with cerebrospinal fluid cultures (IQR, US $3475–6780) compared with US $419 (IQR, US $215–1149) for infants without IBI evaluations (P < 0.001). Five infants (0.2%) returned to the ED within 30 days with new IBI diagnoses (4 bacteremia, 1 meningitis). Conclusions: Invasive bacterial infection occurs infrequently in infants younger than 60 days who present to children's hospital EDs with SSTI. Bacteremia is the most common IBI. More extensive evaluation for IBI is associated with increased rate of admission, LOS, and cost. Further studies are needed to evaluate the safety of a limited IBI evaluation in young infants with SSTI.
- 21 August 2018
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 37 (6) , e301-e306
Invasive Bacterial Infections in Infants Younger Than 60 Days With Skin and Soft Tissue Infections
Objective: The objective of this study was to describe the frequency of invasive bacterial infections (IBIs) in young infants with skin and soft tissue infections (SSTIs) and the impact of IBI evaluation on disposition, length of stay (LOS), and cost. Methods: This retrospective (2009–2014) cohort study used data from 35 children's hospitals in the Pediatric Health Information System. We included infants younger than 60 days who presented to an emergency department (ED) with SSTI. Invasive bacterial infection was defined as bacteremia/sepsis, bone/joint infection, or bacterial meningitis. Readmission and return ED visits within 30 days were evaluated to identify missed IBIs for infants. Results: A total of 2734 infants were included (median age, 33 days; interquartile range [IQR], 21–44); 62% were hospitalized. Invasive bacterial infection was identified in 2%: bacteremia (1.8%), osteomyelitis (0.1%), and bacterial meningitis (0.1%). Hospitalization occurred in 78% of infants with blood cultures, 95% with cerebrospinal fluid cultures, and 23% without cultures. Median hospitalization LOS was 2 days (IQR, 1–3). Median cost was US $4943 for infants with cerebrospinal fluid cultures (IQR, US $3475–6780) compared with US $419 (IQR, US $215–1149) for infants without IBI evaluations (P < 0.001). Five infants (0.2%) returned to the ED within 30 days with new IBI diagnoses (4 bacteremia, 1 meningitis). Conclusions: Invasive bacterial infection occurs infrequently in infants younger than 60 days who present to children's hospital EDs with SSTI. Bacteremia is the most common IBI. More extensive evaluation for IBI is associated with increased rate of admission, LOS, and cost. Further studies are needed to evaluate the safety of a limited IBI evaluation in young infants with SSTI.